Wasatch Advisors Inc. decreased its position in Innospec Inc. (NASDAQ:IOSP) by 1.4% in the 4th quarter, Holdings Channel reports. The firm owned 194,997 shares of the specialty chemicals company’s stock after selling 2,832 shares during the period. Wasatch Advisors Inc.’s holdings in Innospec were worth $13,767,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. SG Americas Securities LLC bought a new position in Innospec in the 2nd quarter worth about $106,000. Victory Capital Management Inc. grew its position in Innospec by 17.7% in the 2nd quarter. Victory Capital Management Inc. now owns 2,720 shares of the specialty chemicals company’s stock worth $178,000 after purchasing an additional 409 shares during the last quarter. Pinebridge Investments L.P. grew its position in Innospec by 1.3% in the 2nd quarter. Pinebridge Investments L.P. now owns 3,180 shares of the specialty chemicals company’s stock worth $209,000 after purchasing an additional 41 shares during the last quarter. Amalgamated Bank grew its position in Innospec by 1.8% in the 2nd quarter. Amalgamated Bank now owns 3,257 shares of the specialty chemicals company’s stock worth $213,000 after purchasing an additional 57 shares during the last quarter. Finally, Suntrust Banks Inc. grew its position in Innospec by 4.0% in the 2nd quarter. Suntrust Banks Inc. now owns 3,996 shares of the specialty chemicals company’s stock worth $261,000 after purchasing an additional 155 shares during the last quarter. Hedge funds and other institutional investors own 91.18% of the company’s stock.
In other news, VP Brian Watt sold 440 shares of the stock in a transaction that occurred on Tuesday, November 21st. The shares were sold at an average price of $70.17, for a total value of $30,874.80. Following the completion of the transaction, the vice president now directly owns 30,730 shares in the company, valued at $2,156,324.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Catherine Hessner sold 707 shares of the stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $71.56, for a total transaction of $50,592.92. Following the completion of the transaction, the vice president now owns 25,791 shares of the company’s stock, valued at $1,845,603.96. The disclosure for this sale can be found here. Insiders sold 24,366 shares of company stock valued at $1,743,891 over the last quarter. Insiders own 2.02% of the company’s stock.
Innospec Inc. (NASDAQ:IOSP) opened at $72.65 on Thursday. The company has a quick ratio of 1.35, a current ratio of 2.24 and a debt-to-equity ratio of 0.30. The stock has a market cap of $1,745.15, a P/E ratio of 20.12 and a beta of 1.21. Innospec Inc. has a 1-year low of $54.10 and a 1-year high of $74.75.
Innospec (NASDAQ:IOSP) last posted its quarterly earnings data on Tuesday, November 7th. The specialty chemicals company reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.15. The business had revenue of $332.40 million during the quarter, compared to analysts’ expectations of $309.40 million. Innospec had a net margin of 7.45% and a return on equity of 15.05%. The business’s revenue was up 61.8% on a year-over-year basis. During the same period last year, the firm posted $0.78 earnings per share. analysts anticipate that Innospec Inc. will post 4.3 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This article was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another publication, it was illegally copied and republished in violation of international copyright and trademark law. The original version of this article can be accessed at https://www.tickerreport.com/banking-finance/3144087/innospec-inc-iosp-holdings-reduced-by-wasatch-advisors-inc.html.
Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP).
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.